Filter Results:
(78)
Show Results For
- All HBS Web
(78)
- News (16)
- Research (52)
- Multimedia (1)
- Faculty Publications (29)
Show Results For
- All HBS Web
(78)
- News (16)
- Research (52)
- Multimedia (1)
- Faculty Publications (29)
- July 2000 (Revised April 2001)
- Case
Agricultural Biotechnology and its Regulation
In the United States, genetically modified corn and soybeans are now widely grown and consumed. In Europe, however, they have been dubbed "Frankenstein foods," shunned by packaged food manufacturers, and subjected to a host of governmental restrictions. This case... View Details
Keywords: Agribusiness; Genetics; Governing Rules, Regulations, and Reforms; Corporate Strategy; Trade; Law; Goods and Commodities; Safety; Environmental Sustainability; Government and Politics; Agriculture and Agribusiness Industry; Biotechnology Industry; Europe; United States
Reinhardt, Forest L. "Agricultural Biotechnology and its Regulation." Harvard Business School Case 701-004, July 2000. (Revised April 2001.)
- 09 Apr 2012
- Research & Ideas
Who Sways the USDA on GMO Approvals?
asking that question through research on the controversial issue of genetically modified organisms (GMOs), agricultural products that are genetically altered to increase yield,... View Details
- January 2011 (Revised July 2012)
- Case
Arcadia Biosciences: Seeds of Change (Abridged)
By: Arthur A. Daemmrich
Arcadia Biosciences is seeking to introduce genetically modified rice to China that will lower farmers' costs and generate environmental benefits through reduced greenhouse gas emissions. The case describes challenges facing this small agricultural biotechnology... View Details
Keywords: Plant-Based Agribusiness; Intellectual Property; Genetics; Environmental Sustainability; Science-Based Business; Climate Change; Agriculture and Agribusiness Industry; Biotechnology Industry; China
Daemmrich, Arthur A. "Arcadia Biosciences: Seeds of Change (Abridged)." Harvard Business School Case 711-050, January 2011. (Revised July 2012.)
- January 2024 (Revised April 2024)
- Case
Target Malaria: Editing Mosquitoes through Gene Drives
By: Shikhar Ghosh and Shweta Bagai
Target Malaria, a non-profit research consortium, is exploring the application of CRISPR-Cas9 gene editing technology to combat malaria in Sub-Saharan Africa. Its approach uses gene drives, a revolutionary tool, to suppress the population of malaria-carrying... View Details
Keywords: Health Disorders; Technological Innovation; Nonprofit Organizations; Business Strategy; Genetics; Ethics; Governing Rules, Regulations, and Reforms; United States; United Kingdom; Burkina Faso; Africa
Ghosh, Shikhar, and Shweta Bagai. "Target Malaria: Editing Mosquitoes through Gene Drives." Harvard Business School Case 824-068, January 2024. (Revised April 2024.)
- October 1998 (Revised December 1999)
- Case
Gene Research, the Mapping of Life and the Global Economy
By: Ray A. Goldberg and Juan Enriquez-Cabot
A new firm is being created to speed up the process of mapping humans, animals, and plants by combining gene technology with rapid gene identification to improve the health and well being of the human population and the productivity of crops and animals. How does one... View Details
Keywords: Information Technology; Organizational Structure; Technological Innovation; Business Processes; Health Care and Treatment; Performance Productivity; Welfare; Agribusiness; Genetics; Science-Based Business; Biotechnology Industry; Agriculture and Agribusiness Industry
Goldberg, Ray A., and Juan Enriquez-Cabot. "Gene Research, the Mapping of Life and the Global Economy." Harvard Business School Case 599-016, October 1998. (Revised December 1999.)
- Research Summary
Professor Hiatt’s research is aimed at discovering how institutional factors can affect sector growth and technology development and adoption by mediating and moderating uncertainty. His work encompasses two related research questions:
1) How can... View Details
- Web
Capstone | MBA
provide guidance across all student interests. While Capstone advisors often include leading experts in their fields, students have the ability to choose capstones across any medical and biotechnology specialty. Recent capstone topics have included bioelectricity,... View Details
- 10 Mar 2015
- First Look
First Look: March 10
and does not turn brown after cutting. Unlike other GMOs, it does not contain foreign genes. The case describes the company's commercialization plans in light of the complex environment surrounding genetically View Details
Keywords: Carmen Nobel
- Web
Food & Agriculture - Business & Environment
Confronting Climate Change Food & Agriculture Innovation will reduce agriculture impacts and help farmers adapt The Green Revolution in the 20 th century dramatically increased crop yields and reduced global poverty by half. [25] These... View Details
- Web
Winners & Runners-Up | New Venture Competition
Winners & Runners-Up 2024 Winners Play Crop Diagnostix: Dubilier Grand Prize Winner, Student Business Track, 2024 New Venture Competition video Play Video duration: 1:31 2024 New Venture Competition Winner, Business Track: View Details
- Web
The New Role for Government & NGOs - Institute For Strategy And Competitiveness
participants. This approach recognizes that helping small farmers increase their yields will not create any lasting benefits unless there are ready buyers for their crops, other enterprises that can process the crops once they are... View Details
- 04 Apr 2024
- News
The Making of a Medical Milestone
On March 16, doctors at the Massachusetts General Hospital made history when they successfully transplanted a kidney from a genetically modified pig to a living human. The groundbreaking procedure marked a significant milestone in animal-to-human transplant, or... View Details
Keywords: Margie Kelley
- 15 Nov 2018
- Book
Can the Global Food Industry Overcome Public Distrust?
JamesBrey Food is the largest segment of the global economy. It is also widely recognized as more critical for human health than any pharmaceutical drug on the planet. But significant changes in the industry are making people lose trust in many institutions involved in... View Details
- 01 Mar 2024
- News
On the Radar
Illustration by Brian Stauffer Illustration by Brian Stauffer Our planet is teeming with trillions of viruses and bacteria, most of which are innocuous or even helpful, but some pose a significant risk to public health, animals, and crops. In recent decades,... View Details
- 27 Sep 2021
- Blog Post
Working to Change the Food System
genetic engineering, we can not only make these microalgae orders of magnitude faster growing and more resource efficient than traditional crops, but also expand the range of materials and products these microalgae can produce, improving... View Details
- 26 Sep 2024
- Blog Post
Syngenta Tomato Vision
years. However, only about 2% of all tested varieties in the greenhouse end up commercialized! Syngenta’s technology differs from genetically modified organisms (GMO) as they only leverage genes that exist... View Details
- 01 Jun 2000
- News
The Business of Biotech
December). Amgen's Epogen (a treatment for anemia in kidney dialysis patients) and Neupogen (which restores white blood cells in cancer patients) generated more than $2 billion in sales last year. As the ability to analyze a patient's View Details
Keywords: Julia Hanna
- 15 Dec 2015
- News
The Year in Ideas 2015
qualities, achieved through the controversial technology of genetic modification. Genetically modified foods, also known as GMOs, are a confusing topic for consumers. In the... View Details
- 07 Apr 2003
- Research & Ideas
Three Steps for Crisis Prevention
genetically modified foods in Europe. Betting the company on a "life sciences" vision, Shapiro had sold or spun off Monsanto's traditional chemical businesses and moved aggressively to acquire seed... View Details
Keywords: by Michael D. Watkins & Max H. Bazerman
- 07 Aug 2000
- Research & Ideas
The Business of Biotech
cells in cancer patients) generated more than $2 billion in sales last year. Millennium Pharmaceuticals: Alan Crane (photo: Shelly R. Harrison) As the ability to analyze a patient's genetic material is developed, however, many believe... View Details